MET and cancer: EMI-137 is a 26 amino acid peptide that binds the cell-surface receptor, hepatocyte growth factor receptor (also known as c-MET, mesenchymal–epithelial transition factor), that is upregulated in several cancer types, including thyroid, hepatocellular, colorectal, and gastroesophageal cancers (21–25).